Patient-reported depression measures in cancer: a meta-review

Hdl Handle:
http://hdl.handle.net/10034/558838
Title:
Patient-reported depression measures in cancer: a meta-review
Authors:
Wakefield, Claire E.; Butow, Phyllis N.; Aaronson, Neil A.; Hack, Thomas F.; Hulbert-Williams, Nicholas J.; Jacobsen, Paul B.
Abstract:
It is unclear which patient-reported depression measures perform best in oncology settings. We conducted a meta-review to integrate the findings of reviews of more than 50 depression measures used in oncology. We searched Medline, PsycINFO, EMBASE and grey literature from 1999-2014 to identify 19 reviews representing 372 primary studies. Eleven reviews were rated as being of high quality. The Hospital Anxiety Depression Scale (HADS) was most thoroughly evaluated, but was limited by cut-point variability. The HADS had moderate screening utility indices and was least recommended in advanced cancer/palliative care. The Beck Depression Inventory was more generalizable across cancer types/disease stages, with good indices for screening and case finding. The Centre of Epidemiology-Depression Scale was the best-weighted measure in terms of responsiveness. This meta-review provides a comprehensive overview of the strengths and limitations of available depression measures. It can inform the choice of the best measure for specific settings and purposes.
Affiliation:
University of Chester
Citation:
Patient-reported depression measures in cancer: a meta-review 2015, 2 (7):635 The Lancet Psychiatry
Publisher:
Lancet
Journal:
The Lancet Psychiatry
Publication Date:
Jul-2015
URI:
http://hdl.handle.net/10034/558838
DOI:
10.1016/S2215-0366(15)00168-6
Additional Links:
http://linkinghub.elsevier.com/retrieve/pii/S2215036615001686
Type:
Article
Language:
en
ISSN:
22150366
Appears in Collections:
Psychology

Full metadata record

DC FieldValue Language
dc.contributor.authorWakefield, Claire E.en
dc.contributor.authorButow, Phyllis N.en
dc.contributor.authorAaronson, Neil A.en
dc.contributor.authorHack, Thomas F.en
dc.contributor.authorHulbert-Williams, Nicholas J.en
dc.contributor.authorJacobsen, Paul B.en
dc.date.accessioned2015-07-03T10:27:43Zen
dc.date.available2015-07-03T10:27:43Zen
dc.date.issued2015-07en
dc.identifier.citationPatient-reported depression measures in cancer: a meta-review 2015, 2 (7):635 The Lancet Psychiatryen
dc.identifier.issn22150366en
dc.identifier.doi10.1016/S2215-0366(15)00168-6en
dc.identifier.urihttp://hdl.handle.net/10034/558838en
dc.description.abstractIt is unclear which patient-reported depression measures perform best in oncology settings. We conducted a meta-review to integrate the findings of reviews of more than 50 depression measures used in oncology. We searched Medline, PsycINFO, EMBASE and grey literature from 1999-2014 to identify 19 reviews representing 372 primary studies. Eleven reviews were rated as being of high quality. The Hospital Anxiety Depression Scale (HADS) was most thoroughly evaluated, but was limited by cut-point variability. The HADS had moderate screening utility indices and was least recommended in advanced cancer/palliative care. The Beck Depression Inventory was more generalizable across cancer types/disease stages, with good indices for screening and case finding. The Centre of Epidemiology-Depression Scale was the best-weighted measure in terms of responsiveness. This meta-review provides a comprehensive overview of the strengths and limitations of available depression measures. It can inform the choice of the best measure for specific settings and purposes.en
dc.language.isoenen
dc.publisherLanceten
dc.relation.urlhttp://linkinghub.elsevier.com/retrieve/pii/S2215036615001686en
dc.rightsArchived with thanks to The Lancet Psychiatryen
dc.subjectDepressionen
dc.subjectcanceren
dc.subjectscreeningen
dc.subjectoncologyen
dc.subjectresponsivenessen
dc.subjectmeta-reviewen
dc.subjectcase-findingen
dc.titlePatient-reported depression measures in cancer: a meta-reviewen
dc.typeArticleen
dc.contributor.departmentUniversity of Chesteren
dc.identifier.journalThe Lancet Psychiatryen
This item is licensed under a Creative Commons License
Creative Commons
All Items in ChesterRep are protected by copyright, with all rights reserved, unless otherwise indicated.